I'd go a step further... you cannot sell a drug unless there is another company prepared to sell a generic version. It's a national security issue. Dual vendor required.
Also, no blocks on re-imports from foreign nations.
Also, no blocks on re-imports from foreign nations.
Imagine you have only pure market that provides 80% total availability for disease remedies. If you want to cover the 20% uncovered case by bringing a non-profit player, you may threaten some of the pure market player. At the end you may have a 60% coverage by for-profit and 40% by non-profit.
The end solution may seems to be less economically efficient but it covers more of the population and I think it is a good thing.